Comparison Overview

Cencora

VS

Johnson & Johnson MedTech

Cencora

None
Last Update: 2025-12-09
Between 750 and 799

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 51,000 worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $290 billion in annual revenue.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 25,517
Subsidiaries: 0
12-month incidents
0
Known data breaches
1
Attack type number
1

Johnson & Johnson MedTech

1 Johnson and Johnson Plaza, New Brunswick, New Jersey, US, 08901
Last Update: 2025-12-09

At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 34,798
Subsidiaries: 13
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/cencoraglobal.jpeg
Cencora
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/johnson-&-johnson-medtech.jpeg
Johnson & Johnson MedTech
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Cencora
100%
Compliance Rate
0/4 Standards Verified
Johnson & Johnson MedTech
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Cencora in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Johnson & Johnson MedTech in 2025.

Incident History — Cencora (X = Date, Y = Severity)

Cencora cyber incidents detection timeline including parent company and subsidiaries

Incident History — Johnson & Johnson MedTech (X = Date, Y = Severity)

Johnson & Johnson MedTech cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/cencoraglobal.jpeg
Cencora
Incidents

Date Detected: 2/2024
Type:Breach
Blog: Blog
https://images.rankiteo.com/companyimages/johnson-&-johnson-medtech.jpeg
Johnson & Johnson MedTech
Incidents

No Incident

FAQ

Johnson & Johnson MedTech company demonstrates a stronger AI Cybersecurity Score compared to Cencora company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Cencora company has historically faced a number of disclosed cyber incidents, whereas Johnson & Johnson MedTech company has not reported any.

In the current year, Johnson & Johnson MedTech company and Cencora company have not reported any cyber incidents.

Neither Johnson & Johnson MedTech company nor Cencora company has reported experiencing a ransomware attack publicly.

Cencora company has disclosed at least one data breach, while the other Johnson & Johnson MedTech company has not reported such incidents publicly.

Neither Johnson & Johnson MedTech company nor Cencora company has reported experiencing targeted cyberattacks publicly.

Neither Cencora company nor Johnson & Johnson MedTech company has reported experiencing or disclosing vulnerabilities publicly.

Neither Cencora nor Johnson & Johnson MedTech holds any compliance certifications.

Neither company holds any compliance certifications.

Johnson & Johnson MedTech company has more subsidiaries worldwide compared to Cencora company.

Johnson & Johnson MedTech company employs more people globally than Cencora company, reflecting its scale as a Hospitals and Health Care.

Neither Cencora nor Johnson & Johnson MedTech holds SOC 2 Type 1 certification.

Neither Cencora nor Johnson & Johnson MedTech holds SOC 2 Type 2 certification.

Neither Cencora nor Johnson & Johnson MedTech holds ISO 27001 certification.

Neither Cencora nor Johnson & Johnson MedTech holds PCI DSS certification.

Neither Cencora nor Johnson & Johnson MedTech holds HIPAA certification.

Neither Cencora nor Johnson & Johnson MedTech holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description

Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description

Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.

Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description

The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N